Charles D Blanke1, Jaime L Masferrer. Show Affiliations » 1. Oregon Health & Science University, Portland, Oreg., USA. blankec@ohsu.edu
Abstract
Entities: Disease Gene
Mesh： See more » Antineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useCisplatin/therapeutic useClinical Trials as TopicCombined Modality TherapyCyclooxygenase 2Cyclooxygenase 2 InhibitorsCyclooxygenase Inhibitors/therapeutic useHumansIsoenzymes/antagonists & inhibitorsMembrane ProteinsMicrotubules/drug effectsNeoplasms/drug therapyNeoplasms/enzymologyPrognosisProstaglandin-Endoperoxide Synthases
Substances： See more » Antineoplastic AgentsCyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsIsoenzymesMembrane ProteinsCyclooxygenase 2PTGS2 protein, humanProstaglandin-Endoperoxide SynthasesCisplatin
Year: 2003 PMID： 12795058 DOI： 10.1159/000071376
Source DB: PubMed Journal: Prog Exp Tumor Res ISSN： 0079-6263